|Articles|February 2, 2017
Emergent BioSolutions
Advertisement
Emergent BioSolutions provides contract manufacturing services for the aseptic fill/finish of vials and syringes: liquid and lyophilized products. Emergent’s sterile injectable manufacturing facility (located in Baltimore, MD) currently produces 20 commercial products and since 1998 has contributed to the development and production of over 200 clinical products.
INTERPHEX Booth #1240
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
2
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
3
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
4
Turning Real-World Data into Actionable Drug Development Insights With AI
5
